Tyra Biosciences Stock Price on December 16, 2024
TYRA Stock | USD 14.07 0.63 4.29% |
If you're considering investing in Tyra Stock, it is important to understand the factors that can impact its price. As of today, the current price of Tyra Biosciences stands at 14.07, as last reported on the 28th of December, with the highest price reaching 14.75 and the lowest price hitting 14.05 during the day. Tyra Biosciences owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.14, which indicates the firm had a -0.14% return per unit of risk over the last 3 months. Tyra Biosciences exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Tyra Biosciences' Risk Adjusted Performance of (0.1), coefficient of variation of (749.75), and Variance of 22.91 to confirm the risk estimate we provide.
At present, Tyra Biosciences' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 237.1 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 33.8 M. . At present, Tyra Biosciences' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 3.04, whereas Price Earnings Ratio is forecasted to decline to (8.98). Tyra Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Tyra |
Sharpe Ratio = -0.1398
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | TYRA |
Estimated Market Risk
4.9 actual daily | 43 57% of assets are more volatile |
Expected Return
-0.68 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Tyra Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tyra Biosciences by adding Tyra Biosciences to a well-diversified portfolio.
Price Book 2.0532 | Book Value 6.852 | Enterprise Value 390.1 M | Enterprise Value Ebitda (6.95) | Shares Float 10.4 M |
Related Headline
Edgewise Therapeutics Headline on 16th of December 2024
Edgewise Therapeutics Announces Positive Topline Results fro... by finance.yahoo.com
BOULDER, Colo., December 16, 2024--Edgewise Therapeutics, Inc., , a leading muscle disease biopharmaceutical company, today announced positive topline results from the Phase 2 CANYON trial of sevasemten in individuals with Becker muscular dystrophy. Sevasemten is an orally administered first-in-class fast skeletal myosin inhibitor designed to protect muscle against contraction-induced damage in muscular dystrophies. The trial met its primary endpoint of change from baseline in CK.
Tyra Biosciences Valuation on December 16, 2024
It is possible to determine the worth of Tyra Biosciences on a given historical date. On December 16, 2024 Tyra was worth 14.92 at the beginning of the trading date compared to the closed value of 15.06. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Tyra Biosciences stock. Still, in general, we apply an absolute valuation method to find Tyra Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Tyra Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Tyra Biosciences' related companies.
Open | High | Low | Close | Volume | |
15.10 | 15.24 | 14.65 | 14.94 | 142,618 | |
12/16/2024 | 14.92 | 15.18 | 14.78 | 15.06 | 83,546 |
15.00 | 15.55 | 14.85 | 15.22 | 186,220 |
Backtest Tyra Biosciences | | | Tyra Biosciences History | | | Tyra Biosciences Valuation | Previous | Next |
Tyra Biosciences Trading Date Momentum on December 16, 2024
On December 17 2024 Tyra Biosciences was traded for 15.22 at the closing time. The top price for the day was 15.55 and the lowest listed price was 14.85 . The trading volume for the day was 186.2 K. The trading history from December 17, 2024 was a factor to the next trading day price jump. The trading price change against the next closing price was 1.06% . The trading price change against the current closing price is 7.97% . |
Tyra Biosciences Fundamentals Correlations and Trends
By evaluating Tyra Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Tyra Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Tyra financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Tyra Biosciences Stock history
Tyra Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Tyra is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Tyra Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Tyra Biosciences stock prices may prove useful in developing a viable investing in Tyra Biosciences
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 42.7 M | 33.8 M | |
Net Loss | -49.8 M | -47.3 M |
Tyra Biosciences Quarterly Net Working Capital |
|
Tyra Biosciences Stock Technical Analysis
Tyra Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Tyra Biosciences Period Price Range
Low | December 28, 2024
| High |
0.00 | 0.00 |
Tyra Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Tyra Biosciences December 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Tyra Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Tyra Biosciences shares will generate the highest return on investment. By undertsting and applying Tyra Biosciences stock market strength indicators, traders can identify Tyra Biosciences entry and exit signals to maximize returns
Tyra Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Tyra Biosciences' price direction in advance. Along with the technical and fundamental analysis of Tyra Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Tyra to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.1) | |||
Jensen Alpha | (0.65) | |||
Total Risk Alpha | (0.78) | |||
Treynor Ratio | (3.11) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Tyra Stock analysis
When running Tyra Biosciences' price analysis, check to measure Tyra Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tyra Biosciences is operating at the current time. Most of Tyra Biosciences' value examination focuses on studying past and present price action to predict the probability of Tyra Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tyra Biosciences' price. Additionally, you may evaluate how the addition of Tyra Biosciences to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |